Michelle Nagtegaal

Ms. Michelle Nagtegaal


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 November 2019 in Pediatric Blood & Cancer
Verified
Journal Article
Open access
PDF file
MTMichelle L. Tas
Michelle L. Tas
MNMichelle Nagtegaal
Michelle Nagtegaal
KKKathelijne Kraal
Kathelijne Kraal
GTGodelieve A.M. Tytgat
Godelieve A.M. Tytgat
NANico G.G.M. Abeling
Nico G.G.M. Abeling
MNMax M. Van Noesel
Max M. Van Noesel
Background: The clinical course of neuroblastoma stage 4S or MS is characterized by a high rate of spontaneous tumor regression and favorable outcome. However, the clinical course and rate of the regression are poorly understood.Methods: A retrospective cohort study was performed, including all patients with stage 4S neuroblastoma without MYCN amplification, from two Dutch centers between 1972 and 2012. We investigated the clinical characteristics, the biochemical activity reflected in urinary catecholamine excretion, and radiological imaging to describe the kinetics of tumor regression, therapy response and outcome.Results: The cohort of 31 patients reached a 10‐year overall survival of 84% ± 7% (median follow‐up 16 years; range, 3.3‐39). During the regressive phase, liver size normalized in 91% of the patients and catecholamine excretion in 83%, both after a median of two months (liver size: range, 0‐131; catecholamines: range, 0‐158). The primary tumors completely regressed in 69% after 13 months (range, 6‐73), and the liver architecture normalized in 52% after 15 months (range, 5‐131). Antitumor treatment was given in 52% of the patients. Interestingly, regression rates were similar for treated and untreated patients. Four of seven patients < 4 weeks old died of rapid liver expansion and organ compression. Three patients progressed to stage 4, 3 to 13 months after diagnosis; all had persistently elevated catecholamines.Conclusion: Patients < 4 weeks old with neuroblastoma stage 4S are at risk of fatal outcome caused by progression of liver metastases. In other patients, tumor regression is characterized by a rapid biochemical normalization that precedes radiological regression.

1 May 2022 in Burns
Verified
Journal Article
Closed access
MLMarie-Louise H.J. Loos
Marie-Louise H.J. Loos
AVAnnebeth Meij-De Vries
Annebeth Meij-De Vries
MNMichelle Nagtegaal
Michelle Nagtegaal
RBRoel Bakx
Roel Bakx
ATA.H. Teeuw
A.H. Teeuw
YLY. Lucas
Y. Lucas

26 November 2024 in Children
Verified
Journal Article
Open access
PDF file
NONina Onkenhout
Nina Onkenhout
HTHeike C. Terlingen
Heike C. Terlingen
MNMichelle Nagtegaal
Michelle Nagtegaal
EPElise van de Putte
Elise van de Putte
SBStephen C. Boos
Stephen C. Boos
CBCharles Berger
Charles Berger
Recently, part I and part II of a series of three papers were published, namely the papers by Vlaming et al

29 April 2025
Verified
Book Chapter
Closed access
PDF file
MNMichelle Nagtegaal
Michelle Nagtegaal
DRDingeman Rijken
Dingeman Rijken
RRRick R. van Rijn
Rick R. van Rijn

11 June 2023
Verified
Book Chapter
Closed access
PDF file
RBRob A. C. Bilo
Rob A. C. Bilo
SRSimon G. F. Robben
Simon G. F. Robben
RRRick R. van Rijn
Rick R. van Rijn
MNMichelle Nagtegaal
Michelle Nagtegaal

17 September 2026
Verified
Book Chapter
Closed access
PDF file
MNMichelle Nagtegaal
Michelle Nagtegaal
RNR. A. J. Nievelstein
R. A. J. Nievelstein
SRS. G. F. Robben
S. G. F. Robben
RRRick R. van Rijn
Rick R. van Rijn